Dear colleague,

We kindly invite you to submit a paper for the section “Materials in
Analysis” of /Separations/ (ISSN 2297-8739; IF: 3.344). This journal is
an international, scientific, peer-reviewed, open access journal
containing research pertaining to separation and purification science
and technology in all areas of chemical, biological, physical science,
and separation performance, published monthly online by MDPI.

/Separations/ is pleased to deliver high-quality author services and
publishing opportunities to researchers and academics all over the
world. To support your scientific research, we will offer some discounts
for your submission, as follows:

Submission before 31 January 2023: 600 CHF
Submission before 28 February 2023: 400 CHF
Submission before 31 March 2023: 200 CHF

More information about the Section “Materials in Analysis”:
https://www.mdpi.com/journal/separations/sections/analysis_materials
I hope this invitation receives your favorable consideration, and look
forward to our future collaboration.

Kind regards,
Ms. Jillian Wang
E-Mail: jillian.wang@mdpi.com

-------------------------
Separations (IF: 3.344; Q2 in Category “CHEMISTRY, ANALYTICAL”
https://www.mdpi.com/journal/separations)
Twitter: @Sep_MDPI ( https://twitter.com/Sep_MDPI)
LinkedIn: Separations MDPI (
https://www.linkedin.com/company/separations-mdpi)
Separations 2023 Travel Award：
https://www.mdpi.com/journal/Separations/awards/1922

Editor's Choice:
Determination of Carminic Acid in Foodstuffs and Pharmaceuticals by
Microchip Electrophoresis with Photometric Detection
https://www.mdpi.com/2297-8739/7/4/72
ESI–LC–MS/MS for Therapeutic Drug Monitoring of Binary Mixture of
Pregabalin and Tramadol: Human Plasma and Urine Applications
https://www.mdpi.com/2297-8739/8/2/21
Enhanced Photocatalytic Activity of CuWO4 Doped TiO2 Photocatalyst
Towards Carbamazepine Removal under UV Irradiation
https://www.mdpi.com/2297-8739/8/3/25

--
--
Disclaimer: The information and files contained in this message are
confidential and intended solely for the use of the individual or entity
to whom they are addressed. If you have received this message in error,
please notify me and delete this message from your system. You may not
copy this message in its entirety or in part, or disclose its contents
to anyone.